Dr. George M Goshua, M.D. Internal Medicine - Hematology Medicare: Accepting Medicare Assignments Practice Location: 6 Devine St, North Haven, CT 06473 Phone: 203-200-4363 |
Andrew Wang, M.D., PH.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 6 Devine St, North Haven, CT 06473 Phone: 203-287-6200 Fax: 203-785-7053 |
Dr. Maida Khan, Internal Medicine Medicare: Medicare Enrolled Practice Location: 4a Devine St, North Haven, CT 06473 Phone: 203-843-9010 Fax: 203-248-1435 |
Dr. Abisola O. Afolalu, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Broadway, North Haven, CT 06473 Phone: 203-234-6500 Fax: 203-234-6503 |
News Archive
Pfizer Inc. announced today that it has initiated the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for crizotinib (PF-02341066), an oral first-in-class anaplastic lymphoma kinase (ALK) inhibitor for the treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors are ALK-positive. Pfizer expects to complete the submission in the first half of 2011.
PAREXEL International Corporation, a leading global biopharmaceutical services provider, announced today that it has achieved a significant milestone by completing its 100th Asian ethnobridging study, which is designed to help biopharmaceutical companies accelerate development for the Asia/Pacific market.
RedBrick Health, the Health EarningsSM company, today announced the launch of its own next-generation, highly interactive health assessment. Integral to RedBrick's Health Earnings System, the company's new health assessment is compact, conversational and graphical, all significant departures from conventional health assessments.
The collaboration will address a gap in analytical tests and standards applied for drugs based on glycoproteins, which now form the majority of approved biopharmaceutical drugs. Current analytical methods for characterizing glycans are time-consuming and difficult to deploy in commercial environments. They are also limited in their ability to detect and analyze minor glycan species.
› Verified 5 days ago